From: The HDL receptor SR-BI is associated with human prostate cancer progression and plays a possible role in establishing androgen independence
Variable
P-value
Risk ratio
95 % Confidence interval
Cancer vs. non-cancer
<0.0001
2.128
1.693–2.675
GS ≥ 7 vs. GS ≤ 6
2.907
1.673–5.050
pT3/pT4 vs. pT2
0.371
1.269
0.739–2.182
Met. pos. vs. met. neg.
0.207
1.351
0.837–2.182